Phase I and pharmacologic study of 9-aminocamptothecin given by 72-hour infusion in adult cancer patients.
Dahut W, Harold N, Takimoto C, Allegra C, Chen A, Hamilton JM, Arbuck S, Sorensen M, Grollman F, Nakashima H, Lieberman R, Liang M, Corse W, Grem J.
Dahut W, et al. Among authors: grem j.
J Clin Oncol. 1996 Apr;14(4):1236-44. doi: 10.1200/JCO.1996.14.4.1236.
J Clin Oncol. 1996.
PMID: 8648379
Clinical Trial.